Different Stages of Cardiovascular–Kidney–Metabolic Syndrome Associated With the Risk of All‐Cause and Cause‐Specific Mortality: Insights From Two Prospective Cohort Studies
Aims Stage 3 in cardiovascular–kidney–metabolic (CKM) syndrome, defined as subclinical cardiovascular disease (CVD), diagnosis often relies on risk equivalents (very high‐risk CKD or high 10‐year CVD risk) due to the limited accessibility of diagnostic tools. A critical unanswered question is whether these two risk‐equ...